Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2005; 11(42): 6701-6706
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6701
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6701
Case | Sex | Age | HBs Ag positivity | Cirrhosis | Tumor stage | Tumor size | Tumor | Encapsulation | Capsule invasion | Vascular invasion | Preoperative serum | |
ALTSG AJCC | (cm) | differentiation | AFP (ng/mL) | |||||||||
1 | F | 51 | Yes | Yes | T2 | T2 | 2.4 | Moderate | Yes | Yes | No | 20 |
2 | M | 75 | Yes | Yes | T2 | T2 | 3.4 | Moderate | Yes | Yes | No | 25 |
3 | M | 52 | Yes | No | T3 | T2 | 10 | Moderate | Yes | No | No | 64 |
4 | M | 44 | Yes | Yes | T3 | T3 | 4 | Well | Yes | Yes | Yes | 69 |
5 | M | 44 | No | Yes | T2 | T2 | 2.6 | Poor | Yes | Yes | No | 73 |
6 | M | 53 | Yes | Yes | T3 | T2 | 8.3 | Poor | Uncertain | Uncertain | No | 100 |
7 | M | 65 | No | Yes | T2 | T2 | 4.4 | Moderate | Yes | No | No | 150 |
8 | F | 41 | Yes | Yes | T3 | T2 | 7 | Well | Yes | Yes | No | 151 |
9 | M | 57 | No | Yes | T3 | T2 | 6 | Poor | Yes | Yes | Yes | 152 |
10 | M | 46 | Yes | Yes | T1 | T1 | 1.2 | Moderate | Yes | Yes | No | 365 |
11 | M | 60 | Yes | Yes | T2 | T2 | 2.2 | Poor | Yes | Yes | No | 618 |
12 | M | 67 | Yes | Yes | T2 | T2 | 2.5 | Moderate | Yes | Yes | No | 1 057 |
13 | M | 48 | Yes | No | T2 | T2 | 4 | Moderate | Yes | No | No | 1 427 |
14 | M | 43 | Yes | No | T2 | T2 | 2.5 | Moderate | Yes | Yes | No | 1 500 |
15 | F | 31 | Yes | Yes | T2 | T2 | 2 | Moderate | Yes | No | No | 2 726 |
16 | M | 40 | Yes | No | T2 | T2 | 1.6 | Moderate | No | No | No | 3 338 |
17 | M | 35 | Yes | No | T3 | T2 | 8 | Poor | Yes | No | No | 5 505 |
18 | M | 42 | Yes | Yes | T2 | T2 | 3.4 | Poor | Yes | Yes | No | 12 185 |
19 | M | 72 | Yes | No | T3 | T3 | 6.5 | Poor | Yes | Yes | No | 42 837 |
Group 1: decreased ST6Gal | Group 2: increased ST6Gal | P1 | |
(n = 7) | (n = 12) | ||
Tumor ST6Gal I activity (mU/mg of protein) | 0.57 (0.47, 0.37-0.59) | 1.76 (1.21, 0.94-1.93) | 0.005 |
Relative tumor ST6Gal I activity (against non-tumor ST6Gal I activity) | 0.46 (0.42, 0.25-0.71)2 | 2.04 (1.51, 1.35-1.88) | <0.001 |
Tumor ST6Gal I mRNA level3 | 1.78 (0.64, 0.24-1.7) | 1.51 (1.08, 0.68-2.6) | N.S4 |
Serum AFP level (ng/mL) | 7687 (680, 246-145045) | 739 (161, 72-1 197) | N.S. |
Serum msAFP percentage (%) | 35 (41, 23-45) | 18 (13, 11-17) | 0.031 |
- Citation: Poon TC, Chiu CH, Lai PB, Mok TS, Zee B, Chan AT, Sung JJ, Johnson PJ. Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma. World J Gastroenterol 2005; 11(42): 6701-6706
- URL: https://www.wjgnet.com/1007-9327/full/v11/i42/6701.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i42.6701